Literature DB >> 15660442

Structural accelerated failure time models for survival analysis in studies with time-varying treatments.

Miguel A Hernán1, Stephen R Cole, Joseph Margolick, Mardge Cohen, James M Robins.   

Abstract

BACKGROUND: In the absence of unmeasured confounding factors and model misspecification, standard methods for estimating the causal effect of time-varying treatments on survival are biased when (i) there exists a time-dependent risk factor for survival that also predicts subsequent treatment and (ii) past treatment history predicts subsequent risk factor level. In contrast, structural models provide consistent estimates of causal effects when unmeasured confounding and model misspecification are absent. The parameters of nested structural models are estimated by g-estimation and those of marginal structural models by inverse probability weighting.
METHODS: We describe a nested structural accelerated failure time model and use it to estimate the total causal effect of highly active antiretroviral therapy (HAART) on the time to AIDS or death among human immunodeficiency virus (HIV)-infected participants of the Multicenter AIDS Cohort and Women's Interagency HIV Studies. The Appendix describes g-estimation and methods to deal with censoring.
RESULTS: Comparing the regime 'always treated' to 'never treated,' the AIDS-free survival time ratio was 2.5 (95% confidence interval [CI]: 1.7, 3.3).
CONCLUSIONS: Our finding of a strongly beneficial effect is consistent with results from randomized trials and from a previous analysis of the same data using a marginal structural Cox model. In contrast, a previous analysis using a standard (non-structural) model did not find an effect of treatment on survival. Copyright 2005 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2005        PMID: 15660442     DOI: 10.1002/pds.1064

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  46 in total

1.  Causal inference from longitudinal studies with baseline randomization.

Authors:  Sengwee Toh; Miguel A Hernán
Journal:  Int J Biostat       Date:  2008-10-19       Impact factor: 0.968

2.  Healthy worker survivor bias in the Colorado Plateau uranium miners cohort.

Authors:  Alexander P Keil; David B Richardson; Melissa A Troester
Journal:  Am J Epidemiol       Date:  2015-04-01       Impact factor: 4.897

Review 3.  The Healthy Worker Survivor Effect: Target Parameters and Target Populations.

Authors:  Daniel M Brown; Sally Picciotto; Sadie Costello; Andreas M Neophytou; Monika A Izano; Jacqueline M Ferguson; Ellen A Eisen
Journal:  Curr Environ Health Rep       Date:  2017-09

4.  It's About Time: A Survival Approach to Gestational Weight Gain and Preterm Delivery.

Authors:  Emily M Mitchell; Stefanie N Hinkle; Enrique F Schisterman
Journal:  Epidemiology       Date:  2016-03       Impact factor: 4.822

5.  Methods for adjusting for bias due to crossover in oncology trials.

Authors:  K Jack Ishak; Irina Proskorovsky; Beata Korytowsky; Rickard Sandin; Sandrine Faivre; Juan Valle
Journal:  Pharmacoeconomics       Date:  2014-06       Impact factor: 4.981

6.  From exposures to population interventions: pregnancy and response to HIV therapy.

Authors:  Daniel Westreich
Journal:  Am J Epidemiol       Date:  2014-02-25       Impact factor: 4.897

7.  The parametric g-formula for time-to-event data: intuition and a worked example.

Authors:  Alexander P Keil; Jessie K Edwards; David B Richardson; Ashley I Naimi; Stephen R Cole
Journal:  Epidemiology       Date:  2014-11       Impact factor: 4.822

8.  An Illustration of Inverse Probability Weighting to Estimate Policy-Relevant Causal Effects.

Authors:  Jessie K Edwards; Stephen R Cole; Catherine R Lesko; W Christopher Mathews; Richard D Moore; Michael J Mugavero; Daniel Westreich
Journal:  Am J Epidemiol       Date:  2016-07-28       Impact factor: 4.897

9.  The hazards of hazard ratios.

Authors:  Miguel A Hernán
Journal:  Epidemiology       Date:  2010-01       Impact factor: 4.822

10.  Estimating the average treatment effect on survival based on observational data and using partly conditional modeling.

Authors:  Qi Gong; Douglas E Schaubel
Journal:  Biometrics       Date:  2016-05-18       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.